The early bactericidal activity of anti-tuberculosis agents

International Journal of Tuberculosis and Lung Disease

Volumn 10, Issue 6, 2006, Pages 591-

  Donald, Peter R ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ETHAMBUTOL; ISONIAZID; LEVOFLOXACIN; OFLOXACIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; BACTERICIDAL ACTIVITY; DOSE RESPONSE; EDITORIAL; HUMAN; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL;

ANTITUBERCULAR AGENTS; HUMANS; MYCOBACTERIUM TUBERCULOSIS;

EID: 33744900356     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (8)

1. Crofton J, Mitchison D A. Streptomycin resistance in pulmonary tuberculosis. Br Med J 1948; 2: 1009-1015.
2. Jindani A, Aber V R, Edwards E A, Mitchison D A. Am Rev Respir Dis 1980; 121: 939-949.
3. Jindani A, Dore C J, Mitchison D A. Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days. Am J Respir Crit Care Med 2003; 167: 1348-1354.
4. Johnson J L, Hadad D J, Boom W H, et al. Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. Int J Tuberc Lung Dis 2006; 10: 1-8.
5. Kennedy N, Berger L, Curram J, et al. Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis. Clin Infect Dis 1996; 22: 827-833.
6. El-Sadr W M, Perlman D C, Matts J P, et al. Evaluation of an intensive intermittent induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Clin Infect Dis 1998; 26: 1148-1158.
7. Kohno S, Koga H, Kaku M, Maesaki S, Hara K. Prospective comparative study of ofloxacin or ethambutol for the treatment of pulmonary tuberculosis. Chest 1992; 102: 1815-1818.
8. Tuberculosis Research Centre, Chennai. Shortening short course chemotherapy: a randomized clinical trial for treatment of smear-positive pulmonary tuberculosis with regimens using ofloxacin in the intensive phase. Indian J Tuberc 2002; 49: 27-38.